A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

Conditions:   Castration-resistant Prostate Cancer;   Non-small Cell Lung Cancer;   Colorectal Cancer Interventions:   Drug: SM08502;   Drug: Abiraterone;   Drug: Prednisone;   Drug: Docetaxel;   Drug: FOLFIRI Protocol;   Drug: Panitumumab Sponsor:   Biosplice Therapeutics, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials